Skip to content

Hypha Labs, Inc.: 10-Q filed 2024-05-20

What Hypha Labs, Inc. reported in its quarterly report filed 2024-05-20 (fiscal Q2 2024): 27 published measures, 82 facts as tagged in accession 0001493152-24-020708.

This filing

Form
10-Q (quarterly report)
Filed
2024-05-20
Fiscal period
fiscal Q2 2024
Accession
0001493152-24-020708 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Hypha Labs, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-03-311,385,344USD
At 2023-09-301,409,464USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-03-311,523,405USD
At 2023-09-303,280,970USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-03-31-471,661USD
At 2023-12-31-2,052,307USD
At 2023-09-30-2,205,106USD
At 2023-03-31-2,907,232USD
At 2022-12-31-2,880,958USD
At 2022-09-30-2,742,872USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-31235,821USD91
2023-10-01 to 2024-03-31387,467USD183
2023-10-01 to 2023-12-31151,646USD92
2023-01-01 to 2023-03-31-67,498USD90
2022-10-01 to 2023-03-31-307,828USD182
2022-10-01 to 2022-12-31-240,330USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-61,123USD183
2022-10-01 to 2023-03-31-141,490USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-1,261,749USD183
2022-10-01 to 2023-03-31-30,123USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-10-01 to 2024-03-312,115,267USD183
2022-10-01 to 2023-03-31231,313USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-03-31-19,374,530USD
At 2023-09-30-19,761,997USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-01-01 to 2024-03-3192,083,084shares91
2023-10-01 to 2024-03-3189,576,328shares183
2023-01-01 to 2023-03-3182,296,820shares90
2022-10-01 to 2023-03-3182,257,534shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-01-01 to 2024-03-3192,083,084shares91
2023-10-01 to 2024-03-3189,576,328shares183
2023-01-01 to 2023-03-3182,296,820shares90
2022-10-01 to 2023-03-3182,257,534shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-01-01 to 2024-03-310USD/shares91
2023-10-01 to 2024-03-310USD/shares183
2023-01-01 to 2023-03-310USD/shares90
2022-10-01 to 2023-03-310USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-01-01 to 2024-03-310USD/shares91
2023-10-01 to 2024-03-310USD/shares183
2023-01-01 to 2023-03-310USD/shares90
2022-10-01 to 2023-03-310USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-01-01 to 2024-03-3148,714USD91
2023-10-01 to 2024-03-3148,714USD183

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-10-01 to 2024-03-31349,484USD183
2022-10-01 to 2023-03-3149,630USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-574,047USD91
2023-10-01 to 2024-03-31-644,611USD183
2023-01-01 to 2023-03-31-174,114USD90
2022-10-01 to 2023-03-31-260,835USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-03-311,385,344USD
At 2023-09-30765,798USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-01-01 to 2024-03-3173,958USD91
2023-10-01 to 2024-03-31158,271USD183
2023-01-01 to 2023-03-3182,707USD90
2022-10-01 to 2023-03-31179,859USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-03-311,523,405USD
At 2023-09-303,121,814USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-03-31102,140USD
At 2023-09-30122,094USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-01-01 to 2024-03-31574,047USD91
2023-10-01 to 2024-03-31644,611USD183
2023-01-01 to 2023-03-31174,114USD90
2022-10-01 to 2023-03-31260,835USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-03-31105,280,155shares
At 2023-09-3087,096,820shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-03-3118,796,541USD
At 2023-09-3017,468,746USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-7,994USD91
2023-10-01 to 2024-03-31-148,975USD183
2023-01-01 to 2023-03-31-121,821USD90
2022-10-01 to 2023-03-31-360,694USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-31182,504USD91
2023-10-01 to 2024-03-31197,247USD183
2023-01-01 to 2023-03-3145,674USD90
2022-10-01 to 2023-03-3185,198USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-01-01 to 2024-03-31566,053USD91
2023-10-01 to 2024-03-31495,636USD183
2023-01-01 to 2023-03-3152,293USD90
2022-10-01 to 2023-03-31-99,859USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-10-01 to 2024-03-31126,533USD183
2022-10-01 to 2023-03-31151,927USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-14,530USD183
2022-10-01 to 2023-03-3133,384USD182

Inspect the source

Entity
Hypha Labs, Inc. / CIK 0001502966
Captured
2026-09-20T09:11:51.459Z
SEC response SHA-256
2390a5a9ed7b5a8fddf6be227a23095f74d95fa8c54d8146429fc13cee141561

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001502966.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))